Apenas educação · revisão profissional necessária

Semaglutide · GLP-1 receptor agonist, FDA-approved

An approved prescription medicine for type 2 diabetes and chronic weight management — explained without hype.

Revisado clinicamente por Bernard Garcia, MD

O que é

Semaglutide is a GLP-1 receptor agonist peptide, sold as Ozempic (type 2 diabetes, 2017), Rybelsus (oral, 2019) and Wegovy (chronic weight management, 2021). It is one of the most-studied medicines on this site, with multi-year trials in tens of thousands of people.

Because it is approved, it has a label, contraindications, a side-effect profile and a reporting system — all things research peptides lack. That does not make it appropriate for everyone.

Como funciona

GLP-1 agonists mimic a gut hormone that slows gastric emptying, increases insulin release when glucose is high and acts on appetite centres in the brain. The approved trials measured A1c and body weight over 68 weeks and longer, with gastrointestinal side effects the most common reason for stopping.

Situação da pesquisa

Área de pesquisa Situação
Type 2 diabetes FDA-approved (Ozempic, Rybelsus)
Chronic weight management FDA-approved (Wegovy)
Cardiovascular risk reduction FDA-approved label expansion (Wegovy, 2024)
Compounded / online copies Restricted after shortage ended · FDA warnings

A situação reflete apenas o contexto da pesquisa publicada e não constitui afirmação de segurança, eficácia ou adequação para qualquer pessoa.

Perguntas frequentes

Is semaglutide a peptide?

Yes. It is a modified peptide, and also an FDA-approved medicine — that approval is what separates it from research peptides.

What are the main contraindications?

The label includes personal or family history of medullary thyroid carcinoma or MEN2, and warnings around pancreatitis, gallbladder disease and gastrointestinal effects. A provider reviews these against your history.

Can I get compounded semaglutide?

The FDA shortage listing ended and compounding of copies is restricted. Products sold online outside a pharmacy are a safety risk. Ask a provider what is lawfully available.

Próximo passo

Próximo passo: uma triagem confidencial de 3 minutos, revisada por um profissional licenciado. Nenhum tratamento é prometido ou insinuado.

Falar com um profissional

Gratuito · cerca de 10 minutos · revisado por um médico licenciado

Educação geral · Não é orientação médica · Aprovação profissional necessária